Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 372

1.

Diffusion of substance abuse treatment: will buprenorphine be a success?

Ling W, Cunningham-Rathner J, Rawson R.

J Psychoactive Drugs. 2004 May;Suppl 2:115-7.

PMID:
15279123
2.
3.

Quality of life among heroin users on buprenorphine versus methadone maintenance.

Ponizovsky AM, Grinshpoon A.

Am J Drug Alcohol Abuse. 2007;33(5):631-42.

PMID:
17891656
4.

Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.

Colker AC.

Issue Brief Health Policy Track Serv. 2002 Dec 31:1-6. Review. No abstract available.

PMID:
12875273
5.

The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving.

Lenné MG, Dietze P, Rumbold GR, Redman JR, Triggs TJ.

Drug Alcohol Depend. 2003 Dec 11;72(3):271-8.

PMID:
14643944
6.

Role of buprenorphine in the management of heroin addiction.

Sung S, Conry JM.

Ann Pharmacother. 2006 Mar;40(3):501-5. Epub 2006 Jan 24. Review.

PMID:
16434562
7.

History and current status of opioid maintenance treatments: blending conference session.

Kreek MJ, Vocci FJ.

J Subst Abuse Treat. 2002 Sep;23(2):93-105. Review.

PMID:
12220607
8.

HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.

Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE.

J Subst Abuse Treat. 2006 Sep;31(2):187-94. Epub 2006 Jul 18. Erratum in: J Subst Abuse Treat. 2006 Oct;31(3):317.

PMID:
16919747
9.

Buprenorphine: blending practice and research.

Ling W, Smith D.

J Subst Abuse Treat. 2002 Sep;23(2):87-92. Review.

PMID:
12220606
10.

Treatment options for opiate addiction.

[No authors listed]

J Ky Med Assoc. 2004 May;102(5):221-4. No abstract available.

PMID:
15152448
11.
12.

Clinical treatment of opioid addiction and dependence.

Ling W, Rawson RA, Compton M.

Methods Mol Med. 2003;84:285-95. No abstract available.

PMID:
12703332
13.

Pharmacologic treatment of heroin-dependent patients.

O'Connor PG, Fiellin DA.

Ann Intern Med. 2000 Jul 4;133(1):40-54. Review.

PMID:
10877739
14.

Pharmacologic treatments for heroin and cocaine dependence.

Kleber HD.

Am J Addict. 2003;12 Suppl 2:S5-S18. Review.

PMID:
12857659
15.

[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].

Loustauneau A, Auriacombe M, Daulouede JP, Tignol J.

Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Review. French.

PMID:
12518080
16.

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Kakko J, Heilig M, Sarman I.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.

PMID:
18355989
17.

Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.

Ling W, Rawson RA, Compton MA.

J Psychoactive Drugs. 1994 Apr-Jun;26(2):119-28. Review.

PMID:
7931856
18.

Buprenorphine and naloxone interactions in methadone maintenance patients.

Mendelson J, Jones RT, Welm S, Brown J, Batki SL.

Biol Psychiatry. 1997 Jun 1;41(11):1095-101.

PMID:
9146820
19.

Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.

Longshore D, Annon J, Anglin MD, Rawson RA.

Addiction. 2005 Aug;100(8):1131-9.

20.

Pharmacotherapy of addictions.

Kreek MJ, LaForge KS, Butelman E.

Nat Rev Drug Discov. 2002 Sep;1(9):710-26. Review. Erratum in: Nat Rev Drug Discov 2002 Nov;1(11):920.

PMID:
12209151

Supplemental Content

Support Center